Epigenetic Factor MicroRNAs Likely Mediate Vaccine Protection Efficacy against Lymphomas in Response to Tumor Virus

Lei Zhang1,2, Qingmei Xie3, Shuang Chang4

  • 1U.S. Department of Agriculture, Agricultural Research Service, U.S. National Poultry Research Center, Athens, GA 30605, USA.

Veterinary Sciences
|April 26, 2024
PubMed

Insights

This study identified specific microRNAs (miRNAs) in chickens that change after Marek's disease vaccination and virus challenge. These miRNAs may influence vaccine effectiveness by affecting cancer-related signaling pathways.

Area of Science:

  • Animal Science
  • Immunology
  • Molecular Biology

Background:

  • Epigenetic factors, like microRNAs (miRNAs), regulate gene expression and are crucial for biological processes, including anti-tumor immunity.
  • Marek's disease (MD), a contagious chicken disease caused by the MD virus (MDV), is managed through vaccination, whose efficacy may involve host epigenetic modifications.

Purpose of the Study:

  • To identify differentially expressed miRNAs in the bursae of Fabricius in response to MD vaccination and subsequent MDV challenge.
  • To investigate the role of these miRNAs in vaccine efficacy by analyzing their target genes and associated signaling pathways in genetically divergent chicken lines.

Main Methods:

  • Small RNA sequencing and bioinformatic analyses were performed on bursae of Fabricius from two inbred White Leghorn lines (resistant line 63 and susceptible line 72).
  • Birds were subjected to vaccination (HVT or CVI988/Rispens) followed by MDV challenge.
  • Differential miRNA expression analysis and Gene Ontology (GO) analysis of target genes were conducted.

Main Results:

  • Hundreds of miRNAs were identified, with a subset showing differential expression across treatment groups.
  • A direct comparison between vaccinated resistant and susceptible lines revealed five differentially expressed miRNAs.
  • GO analysis indicated that the target genes of these five miRNAs are involved in critical signaling pathways such as MAPK, TGF-β, ErbB, and EGFR1.

Conclusions:

  • The identified differentially expressed miRNAs likely play a role in modulating vaccine protection against Marek's disease.
  • These miRNAs may influence anti-cancer immunity and disease progression through their involvement in key oncogenic and anti-cancer signaling pathways.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K